DDrare: Database of Drug Development for Rare Diseases

Cholic acids (DrugBank: -)

2 diseases

ID	Disease name (Link within this page)	Number of trials
20	Adrenoleukodystrophy	1
234	Peroxisomal disease (except Adrenoleukodystrophy)	1

20. Adrenoleukodystrophy [ 49 clinical trials, 86 drugs, (DrugBank: 29 drugs), 18 drug target genes, 112 drug target pathways]

Searched query = "Adrenoleukodystrophy", "Adrenomyeloneuropathy", "AMN"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 49 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00007020 (ClinicalTrials.gov)	January 1992	6/12/2000	Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid	Investigation in the Pathogenesis of Liver Disease in Patients With Inborn Errors of Bile Acid Metabolism	Infantile Refsum's Disease;Zellweger Syndrome;Adrenoleukodystrophy;Peroxisomal Disorders;Cholestasis	Drug: Cholic Acids	Travere Therapeutics, Inc.	Children's Hospital Medical Center, Cincinnati	Completed	N/A	N/A	All	85	Phase 3	United States

234. Peroxisomal disease (except Adrenoleukodystrophy) [ 38 clinical trials, 37 drugs, (DrugBank: 12 drugs), 12 drug target genes, 42 drug target pathways]

Searched query = "Peroxisomal disease (except Adrenoleukodystrophy)", "Peroxisomal disease", "Peroxisomal disorder", "Peroxisome biogenesis disorder", "PEX gene disord ... show all
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 38 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00007020 (ClinicalTrials.gov)	January 1992	6/12/2000	Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid	Investigation in the Pathogenesis of Liver Disease in Patients With Inborn Errors of Bile Acid Metabolism	Infantile Refsum's Disease;Zellweger Syndrome;Adrenoleukodystrophy;Peroxisomal Disorders;Cholestasis	Drug: Cholic Acids	Travere Therapeutics, Inc.	Children's Hospital Medical Center, Cincinnati	Completed	N/A	N/A	All	85	Phase 3	United States